Frontal dopaminergic abnormality in Tourette syndrome: A postmortem analysis

[1]  E. Fernandez-Egea,et al.  Lower striatal dopamine transporter binding in neuroleptic-naive schizophrenic patients is not related to antipsychotic treatment but it suggests an illness trait , 2007, Psychopharmacology.

[2]  Tyrone D. Cannon,et al.  Brain dopamine d1 receptors in twins discordant for schizophrenia. , 2006, The American journal of psychiatry.

[3]  R. Levenson,et al.  Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex , 2006, Neuroreport.

[4]  B. Peterson,et al.  Interhemispheric connectivity and executive functioning in adults with Tourette syndrome. , 2006, Neuropsychology.

[5]  J. Pavía,et al.  Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism , 2005, Psychopharmacology.

[6]  H. Singer,et al.  Tourette's syndrome: from behaviour to biology , 2005, The Lancet Neurology.

[7]  Bradley T. Christian,et al.  Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET , 2005, Brain Research.

[8]  A. Toga,et al.  Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats , 2005, Journal of Neural Transmission / General Section JNT.

[9]  A. Grace,et al.  Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia , 2005, Journal of Neural Transmission / General Section JNT.

[10]  Tore Wentzel-Larsen,et al.  Altered interhemispheric connectivity in individuals with Tourette's disorder. , 2004, The American journal of psychiatry.

[11]  H. Singer,et al.  Increased prefrontal D2 protein in Tourette syndrome: a postmortem analysis of frontal cortex and striatum , 2004, Journal of the Neurological Sciences.

[12]  M. Trimble,et al.  Dopamine transporter binding in Gilles de la Tourette syndrome: a [123I]FP‐CIT/SPECT study , 2004, Acta psychiatrica Scandinavica.

[13]  J. Lee,et al.  Dopamine transporter density of the basal ganglia assessed with [123I]IPT SPECT in drug-naive children with Tourette's disorder , 2003, Psychiatry Research: Neuroimaging.

[14]  T. Reader,et al.  Neuroleptics and Dopamine Transporters , 2004, Neurochemical Research.

[15]  J. Korf,et al.  Neurobiology and neuroimmunology of Tourette’s syndrome: an update , 2004, Cellular and Molecular Life Sciences CMLS.

[16]  H. Singer,et al.  Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities , 2003, Brain and Development.

[17]  John W Haycock,et al.  Marked disparity between age‐related changes in dopamine and other presynaptic dopaminergic markers in human striatum , 2003, Journal of neurochemistry.

[18]  E. Bromfield,et al.  Tourette’s syndrome following temporal lobectomy for seizure control , 2003, Epilepsy & Behavior.

[19]  Thomas E. Nichols,et al.  Increased ventral striatal monoaminergic innervation in Tourette syndrome , 2003, Neurology.

[20]  Alfredo Berardelli,et al.  Pathophysiology of tics and Tourette syndrome , 2003, Journal of Neurology.

[21]  Reinhard Dengler,et al.  Disturbed Monitoring and Response Inhibition in patients with Gilles De La Tourette Syndrome and Co-Morbid Obsessive Compulsive Disorder , 2003, Behavioural neurology.

[22]  J. Mattingley,et al.  Abnormal line bisection judgements in children with Tourette's syndrome , 2002, Neuropsychologia.

[23]  Jeremy K Seamans,et al.  Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex. , 2002, Journal of neurophysiology.

[24]  Yun Zhou,et al.  Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. , 2002, The American journal of psychiatry.

[25]  Kjell Någren,et al.  Age‐related loss of extrastriatal dopamine D2‐like receptors in women , 2002, Journal of neurochemistry.

[26]  S. Reeves,et al.  Ageing and the nigrostriatal dopaminergic system , 2002, International journal of geriatric psychiatry.

[27]  M. Wiesendanger,et al.  Movement control of manipulative tasks in patients with Gilles de la Tourette syndrome. , 2002, Brain : a journal of neurology.

[28]  D. Zee,et al.  Oculomotor abnormalities in boys with tourette syndrome with and without ADHD. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[29]  S Tanada,et al.  Age-related reduction of extrastriatal dopamine D2 receptor measured by PET. , 2001, Life sciences.

[30]  D. Durstewitz,et al.  Bidirectional Dopamine Modulation of GABAergic Inhibition in Prefrontal Cortical Pyramidal Neurons , 2001, The Journal of Neuroscience.

[31]  J. Joyce,et al.  D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: Influence of withdrawal period , 2001, Synapse.

[32]  J C Gore,et al.  Regional brain and ventricular volumes in Tourette syndrome. , 2001, Archives of general psychiatry.

[33]  T. Sejnowski,et al.  Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. Singer,et al.  Executive function in fluency and recall measures among children with Tourette syndrome or ADHD , 2001, Journal of the International Neuropsychological Society.

[35]  F. Mora,et al.  Endogenous dopamine potentiates the effects of glutamate on extracellular GABA in the prefrontal cortex of the freely moving rat , 2000, Brain Research Bulletin.

[36]  E Stern,et al.  A functional neuroanatomy of tics in Tourette syndrome. , 2000, Archives of general psychiatry.

[37]  W. McMahon,et al.  The Tourette Syndrome Diagnostic Confidence Index , 1999, Neurology.

[38]  W. Paulus,et al.  Deficient motor control in children with tic disorder: evidence from transcranial magnetic stimulation , 1999, Neuroscience Letters.

[39]  J. Seamans,et al.  Developing a Neuronal Model for the Pathophysiology of Schizophrenia Based on the Nature of Electrophysiological Actions of Dopamine in the Prefrontal Cortex , 1999, Neuropsychopharmacology.

[40]  B. Biswal,et al.  Blind source separation of multiple signal sources of fMRI data sets using independent component analysis. , 1999, Journal of computer assisted tomography.

[41]  A. Anderson,et al.  A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. , 1998, Archives of general psychiatry.

[42]  M. Millan,et al.  Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release , 1998, Neuroscience.

[43]  P. Goldman-Rakic,et al.  Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsychotic drugs. , 1997, The Journal of pharmacology and experimental therapeutics.

[44]  A L Reiss,et al.  Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder , 1996, Neurology.

[45]  P. Goldman-Rakic,et al.  Localization of dopamine D4 receptors in GABAergic neurons of the primate brain , 1996, Nature.

[46]  Linda J. Schuerholz,et al.  Neuropsychological status of children with Tourette's syndrome with and without attention deficit hyperactivity disorder , 1996, Neurology.

[47]  R. Rivest,et al.  Brain dopamine transporter: gender differences and effect of chronic haloperidol , 1995, Brain Research.

[48]  H. Singer,et al.  Second messenger systems in Tourette's syndrome , 1995, Journal of the Neurological Sciences.

[49]  R. Kötter.  Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum , 1994, Progress in Neurobiology.

[50]  P S Goldman-Rakic,et al.  D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[51]  James S. Duncan,et al.  Corpus callosum morphology from magnetic resonance images in Tourette's syndrome , 1994, Psychiatry Research: Neuroimaging.

[52]  P. Goldman-Rakic,et al.  A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[53]  I. Hanbauer,et al.  Comparison of [3H]WIN 35,428 Binding, a Marker for Dopamine Transporter, in Embryonic Mesencephalic Neuronal Cultures with Striatal Membranes of Adult Rats , 1993, Journal of neurochemistry.

[54]  G. Sedvall,et al.  Effect of raclopride on dopamine D2 receptor mRNA expression in rat brain , 1992, Neuroscience.

[55]  B. Bloch,et al.  Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: A quantitative in situ hybridization study , 1991, Neuroscience.

[56]  H. Singer,et al.  Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome , 1991, Annals of neurology.

[57]  A. D. Smith,et al.  The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones , 1990, Trends in Neurosciences.

[58]  H. Singer,et al.  Tourette's syndrome: A neurochemical analysis of postmortem cortical brain tissue , 1990, Annals of neurology.

[59]  D. Cohen,et al.  The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.

[60]  G Maura,et al.  Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals. , 1988, The Journal of pharmacology and experimental therapeutics.

[61]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[62]  E. Richelson,et al.  Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. , 1984, European journal of pharmacology.